|
May31
|
 My interview today (the third one this week) is with a person I come a long way with. She was a former colleague, an old time friend who introduced me to the wonders of blogging and problogging.
She too is a colleague (not to mention friend) in the science blogosphere and is also my sister at the former About Weblogs Network.
In addition, Ruth has been witness to major events in my life and I was maid of honor at her wedding.
Have I mentioned already that we’ve come a long long way? He he.
Anyway, back to business…here’s Ruth Schaffer:
|
|
May31
|
Naltrexone, an FDA approved drug to ease symptoms of alcohol and drug addiction has been found in a Penn State College of Medicine pilot study to bring relief to people with Crohn’s disease. Crohns’s disease is a chronic inflammatory disorder...
Continue Reading
|
|
|
The USFDA recently approved Duramed Pharmaceuticals, Inc. and Barr Pharmaceuticals, Inc.’s New Drug Application (NDA) for SEASONIQUE™ (levonorgestrel/ethinyl estradiol tablets 0.15 mg/0.03 mg and ethinyl estradiol tablets 0.01 mg) extended-cycle oral contraceptive for the prevention of pregnancy. In July 2006,...
Continue Reading
|
|
|
According to the results of a Phase IIIb clinical trial, Shire plc’s methylphenidate transdermal system (MTS), DAYTRANA™, is significantly efficient in reducing the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 to 12 years during shorter wear...
Continue Reading
|
|
|
The USFDA recently granted accelerated approval to Celgene Corporation’s Supplemental New Drug Application (sNDA) for THALOMID (thalidomide) in combination with dexamethasone for the treatment of newly diagnosed multiple myeloma. In the United States (affecting approximately 50,000 people) multiple myeloma is...
Continue Reading
|
|
May30
|
My second interview is with the beauty blogger, Christina Jones. Christina is also a sister in the former About Weblogs Network. (you see it pays to have ‘sisters" in the blogosphere, they will agree to any interview even with their...
Continue Reading
|
|
|
Lupin Pharmaceuticals, Inc.’s Abbreviated New Drug Application (ANDA) for its Cefdinir Capsules, 300 mg has been granted final approval by the USFDA. Cefdinir Capsules, an extended-spectrum semisynthetic cephalosporin used to treat or prevent infections that are proven or strongly suspected...
Continue Reading
|
|
|
Wyeth Pharmaceutical’s (a Wyeth Division) investigational drug for major depressive disorder (MDD) -desvenlafaxine succinate (DVS-233), passed its Phase 3 clinical trial. The data and results of the study involving this novel serotonin-norepinephrine reuptake inhibitor (SNRI) have been presented at the...
Continue Reading
|
|
|
Angiotension converting enzyme (ACE) inhibitors are medication type commonly used to lower blood pressure. In a study presented at the recent Digestive Disease Week® 2006, researchers found that ACE inhibitors may be doing more that treating the patients’ hypertension but...
Continue Reading
|
|
May29
|
This is interview week at Know More Media and here at The Pharm Voice, I will be posting interviews from people that are either connected or experts in the Pharmaceutical Industry, as well as seasoned probloggers in various fields of...
Continue Reading
|
|
|
Vocal Fold Insufficiency is a common voice-altering condition that is a serious form of voice loss where one or both vocal folds (and chords) lack the physical capacity to properly vibrate. Treatment of such a condition with Radiesse™ has been...
Continue Reading
|
|
|
SSc or systemic sclerosis is generally considered and treated as an autoimmune inflammatory disorder which cause and cure is yet to be found. Also known as scleroderma, SSc is an uncommon, mysterious disease by which excessive fibrous are formed including...
Continue Reading
|
|
|
The cells in the anus, when infected by ‘high risk” forms of HPV (the virus that causes warts) is a pre-cancerous condition called AIN (anal intraepithelial neoplasia). This condition which is not easily treated even by antiretroviral therapy is more...
Continue Reading
|
|
|
Gaucher's (pronounced go-SHAYZ) disease is a rare but a most common lysosomal storage disorder and genetic disorder affecting Jewish people of Eastern European ancestry. Gaucher's disease is fatal condition wherein a defective form of GC is produced. GC is a...
Continue Reading
|
|
May27
|
ProEthic Pharmaceuticals announced that it has initiated Phase III clinical trials for PRO-513, the company's drug candidate for migraine headaches. PRO-513 is a formulation of diclofenac potassium powder for oral solution, which utilizes a unique, patented Dynamic Buffering Technology (DBT)...
Continue Reading
|
|
|
French biopharmaceutical bioMerieux is selling its hemostasis range of products to Trinity Biotech plc for a total value nearing $60 million, including collectibles. The operations sold include the automated and semi-automated hemostasis analyzers, as well as a comprehensive range of...
Continue Reading
|
|
May26
|
As reported recently at boston.com, Novartis AG will launch an anti-malaria project in search of a one-dose cure for the most dangerous type of malaria. The research will be undertaken by the company’s tropical disease institute in Singapore, utilizing $20...
Continue Reading
|
|
|
Treatment with the investigational drug lisdexamfetamine dimesylate (NRP104) showed a statistically significant reduction in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 years as demonstrated by the results oaf a Phase III Clinical Trial recently presented...
Continue Reading
|
|
|
A generic version of the antidepressant Lexapro (escitalopram oxalate) has been approved by the US FDA. The generic tablets, manufactured by Israel-based Teva Pharmaceuticals, will be available in three doses: 5 mg, 10 mg, and 20 mg. The drug is...
Continue Reading
|
|
May25
|
The proton pump inhibitor (PPI) NEXIUM® (esomeprazole magnesium) maintained normal gastric (stomach) acid levels in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion (IGH), according to the results of a 12-month multi-center study which were presented at the annual...
Continue Reading
|
|
|
The USFDA approved Remicade (infliximab) for treatment of children with active Crohn's disease. Crohn’s disease is a chronic, inflammatory condition of the bowel that can be severely debilitating. Remicade which was initially approved in 1998 for treatment of Chron’d disease...
Continue Reading
|
|
|
Early this year, patient recruitment for the clinical trial of Roche's post-surgical colon cancer adjuvant therapeutic, AVANT, were suspended following the death of 6 patients involved in the study. However, Roche announced that it will now resume recruitment, upon clearance...
Continue Reading
|
|
|
Pharmacopeia and Cephalon, Inc. have formed a partnership to discover, develop and commercialize new drugs. Under the terms of agreement, the "division of labor" between the two firms are clear: 1. Cephalon will be responsible for identifying promising compounds. 2....
Continue Reading
|
|
|
SkyePharma PLC and First Horizon Pharmaceutical Corporation will co-develop a novel controlled-release version of Sular (nisoldipine), First Horizon's antihypertensive product. Nisoldipine is a calcium channel blocker that prevents calcium from entering certain types of muscle cells. Because muscle cells need...
Continue Reading
|
|
May24
|
According to a study that was presented at the American Thoracic Society International Conference on May 22nd, lung transplant patients who received the inhaled form of the anti-rejection drug cyclosporine had significantly better lung function. "Many lung transplant patients develop...
Continue Reading
|
|
|
Researchers at the University of Georgia have provided vaccine developers with a new tool that could lead to the development of novel vaccines that will protect against a wider range of diseases or work against diseases that are currently hard...
Continue Reading
|
|
|
GeoVax, Inc. has started its HIV/AIDS human clinical trials in different sites around the United States. The culmination of this study is in lieu of the recently received "Safe to Proceed" status for a new Investigational New Drug (IND) from...
Continue Reading
|
|
|
According to an animal model study conducted by University of Pittsburgh School of Medicine researchers whose results have been presented at the annual meeting of the American Urological Association, IP 751, a potent synthetic analog of a metabolite of THC...
Continue Reading
|
|
|
As reported last week at CNN, FDA has approved a new drug, Azilect (also called rasagiline), which helps block the breakdown of a chemical that contributes to problems with movement and coordination (dopamine) that marks Parkinson’s disease. Azilect has been...
Continue Reading
|
|
May23
|
Lentigen Corporation went into an exclusive, worldwide licensing agreement with the University of Pennsylvania , relating to lentiviral vector technology. Lentiviral vectors ( LV ) are vehicles that can deliver genes or RNAi into cells with up to 100% efficiency...
Continue Reading
|
|
|
Corgentech Inc. recently announced the positive results of one of its two pivotal Phase 3 studies of its lead product candidate, 3268 (a fast-acting local anesthetic) which showed statistically significant reduction in pain when administered just one to three minutes...
Continue Reading
|
|
|
Codeine, a standard ingredient in cough remedies may not be effective in treating cough, according to scientists at the University of Manchester's North West Lung Centre. Lead researcher Dr. Jacyln Smith said: "Codeine has long been considered the standard anti-cough...
Continue Reading
|
|
|
The US FDA granted tentative approval to abacavir sulfate tablets, the first generic anti-HIV medication manufactured by Hyderabad-based Aurobindo Pharma LTD. This product will now be available for consideration for purchase under the government's Emergency Plan for AIDS Relief. "FDA's...
Continue Reading
|
|
|
Vertex Pharmaceuticals Incorporated announced that, in Phase II clinical studies, in combination with pegylated interferon alfa-2a (Pegasys®; peg-IFN) and ribavirin (RBV), the company's lead candidate against hepatitis C virus (HCV), VX-950 reduced HCV RNA to undetectable levels in 100% of...
Continue Reading
|
|
May22
|
Carrington Laboratories, Inc. has received a U.S. Patent describing the pharmacological compositions that expand the company's technology base and help protect the antigen sparing influenza vaccines which DelSite Biotechnologies, Inc. (Carrington's wholly-owned subsidiary) is developing and commercializing. Because of vaccine...
Continue Reading
|
|
|
Pharsight Corporation, a leading provider of software and strategic services for optimizing clinical drug development, has recently been awarded a patent for interactively building pharmacokinetic and pharmacodynamic ("PK/PD") models using a graphical interface (U.S. Application No. 7,043,415). This patented graphical...
Continue Reading
|
|
|
HemoBiotech, Inc. recently announced that Texas Tech University has filed a patent application for induction of erythropoiesis (red blood cell production) by HemoTech™, a novel chemically modified hemoglobin that is being developed as a blood substitute, which HemoBiotech has worldwide...
Continue Reading
|
|
|
An affiliate of Harvard Medical School, Schepens Eye Research Institute is the first to discover a switch inside blood vessel cells that controls angiogenesis (new blood vessel growth), which is turned on and off by the balance between two enzymes...
Continue Reading
|
|
|
Baxter AG and Jerini AG recently announced the progress of their collaborative research program that aims to develop a non-intravenous therapy for the treatment of hemophilia, in which extensive in vitro and in vivo analyses have identified several synthetic lead...
Continue Reading
|
|
May21
|
The June 1 issue of G&D reported a novel animal model developed by Drs. Katerina Politi, Harold Varmus and colleagues at the Memorial Sloan Kettering Cancer Center in New York, of lung adenocarcinoma that will be of great use in...
Continue Reading
|
|
|
Valeant Pharmaceuticals International announced last week that the US FDA has given marketing approval for Cesamet (CII) (nabilone) oral capsules, a synthetic cannabinoid for treating nausea and vomiting associated with cancer chemotherapy in patients with whom anti-emetic treatments have failed....
Continue Reading
|
|
|
Nutrition 21, developer and marketer of chromium-based nutritional supplements, announced Friday that it has raised $10 million in private placements, with more than 5.5 million shares of common stock at $1.80 per share. Paul Intlekofer, President and Chief Executive Officer...
Continue Reading
|
|
|
Novavax, Inc. and Esprit Pharma entered into a definitive agreement to co-develop, supply and commercialize Novavax's testosterone lotion currently under Phase 2 clinical trials for female hypoactive sexual desire disorder (HSDD). Under terms of the License Agreement, Esprit will receive...
Continue Reading
|
|
|
Alfacell Corporation will lead a groundbreaking program to be conducted in Turkey to evaluate the potential of ONCONASE® (ranpirnase) and other medications to prevent mesothelioma. "Our hypothesis is that ONCONASE®, with its proven affinity for rapidly-dividing cancerous cells, inhibition of...
Continue Reading
|
|
May20
|
Inverness Medical Innovations, Inc. has acquired a newly-constructed manufacturing facility in Hangzhou, China, as part of its acquisition of ACON Laboratories' business of researching, developing, manufacturing, marketing and selling lateral flow immunoassay products in the United States, Canada, Western Europe,...
Continue Reading
|
|
|
Shire Laboratories Inc., a subsidiary of Shire plc has filed a lawsuit in the U.S. District Court for the District of New Jersey against Corepharma LLC for infringement of Shire Laboratories' U.S. Patent Nos. 5,326,570 ("'570 Patent") and 5,912,013 ("'013...
Continue Reading
|
|
|
The International Clinical Trials Registry Platform is a major initiative aimed at standardizing the way information on medical studies is made available to the public through a process called registration. In lieu of this, the World Health Organization (WHO)...
Continue Reading
|
|
|
A recent report published at the Journal of the National Cancer Institute showed that women who are on statins (the widely used cholesterol-lowering drugs) are not on increased risk of breast cancer, contradicting what has been reported in previous studies....
Continue Reading
|
|
|
Brittle bone disorder or osteogenesis imperfecta (OI) is an inherited disorder characterized by weak bones that break easily and people inflicted with the most severe form of this disorder have short stature, can suffer hundreds if not thousands of fractures...
Continue Reading
|
|
May19
|
The USFDA recently issued a warning letter to young adults who are using the antidepressant Paxil, stating that this drug may increase the risk of suicidal behavior in young adults. The warning letter came with the changes in labeling of...
Continue Reading
|
|
|
The University of Central Florida researchers have recently discovered a gene known as MCPIP could provide scientists with the key to developing treatments for preventing inflammation that can cause heart disease. A research team led by Pappachan Kolattukudy, dean of...
Continue Reading
|
|
|
Coreg CR™ (carvedilol phosphate controlled-release capsules) is a controlled-release beta blocker that reduced blood pressure over a full 24-hour dosing interval according to the data presented at the recent American Society for Hypertension 21st Annual Scientific Meeting and Exposition in...
Continue Reading
|
|
|
Targacept Inc.’s TC-1734 (AZD3480) passed its Phase II clinical trial in age associated memory impairment (AAMI). TC-1734 (AZD3480) is a highly selective alpha4 beta2 neuronal nicotinic receptor (NNR) agonist which was discovered using Pentad™, a sophisticated computer-based molecular design platform...
Continue Reading
|
|
|
VX—770, Vertex Pharmaceuticals Inc.’s novel oral drug candidate that specifically targets a key mechanism underlying cystic fibrosis (CF) has been granted Fast Track Designation by the USFDA. The company recently announced that it has started the Phase I clinical study...
Continue Reading
|
|
May18
|
Neotropix™, Inc.’s Investigational New Drug (IND) application for its very first cancer drug candidate called Seneca Valley Virus (SVV-001), has been approved by the USFDA. The approval means that Neotropix™, Inc. (biotechnology company developing oncolytic viruses for the treatment of...
Continue Reading
|
|
|
The USFDA granted Fast Track Status to Coley Pharmaceutical Group, Inc.’s ACTILON™ (CPG 10101) for use in treatment-refractory patients chronically infected with the Hepatitis C Virus (HCV). "A Fast Track designation for our ACTILON™ development program allows Coley to work...
Continue Reading
|
|
|
Amarin Corporation plc acquired the global rights to a novel formulation of apomorphine for the treatment of "off" episodes in patients with advanced Parkinson's disease. The novel oral formulation provides rapid absorption of apomorphine directly into the bloodstream after sublingual...
Continue Reading
|
|
|
A joint collaboration has been developed between Families of Spinal Muscular Atrophy (FSMA) and Paratex Pharmaceuticals, Inc. in developing a promising drug candidate for the treatment of Spinal Muscular Atrophy (SMA). SMA is the leading genetically inherited cause of death...
Continue Reading
|
|
|
A study headed by Mayo Clinic found that rheumatoid arthritis (RA) patients taking the drugs Humira® or Remicade have thrice the risk of developing several kinds or cancer and double the risk of getting serious infections. Humira® is made by...
Continue Reading
|
|
May17
|
Rockville, MD-based biopharmaceutical firm MacroGenics has raised $45 million in its third round of venture capital financing round. In addition to all precious investors, this round, led by Ventures West, brings in a new set of VCs: Caisse de dépôt...
Continue Reading
|
|
|
According to University of Cincinnati researchers, a cell-signaling pathway in the brain that is linked to the development of cancer and diabetes is also a key part of networks that regulate food intake. This finding will one day lead to...
Continue Reading
|
|
|
According to a study published at the British Medical Journal website, some ethnic groups may be more susceptible to adverse drug reactions (ADRs), which are an important cause if illness and death. Genetic make-up, age, sex and even diet are...
Continue Reading
|
|
May16
|
Bristol-Myers Squibb’s ORENCIA®, selective modulator of a co- stimulatory signal required for full T-cell activation, for the treatment of rheumatoid arthritis (RA), has been approved by the USFDA in December 2005. Following this approval, the company recently announced the USFDA...
Continue Reading
|
|
|
Evamist™ is VIVUS, Inc.’s investigational estradiol metered dose transdermal spray that is being developed for the treatment of vasomotor symptoms associated with menopause. VIVUS, Inc. recently announced the positive results from the pivotal Phase 3 clinical trial of Evamist™ which...
Continue Reading
|
|
|
Remoxy™ is DURECT Corporation’s abuse-resistant pain medicine under development based on the company’s patented ORADUR™ technology incorporating the opioid oxycodone. Remoxy™ is currently undergoing a pivotal Phase III program as announced by DURECT recently which was spearheaded by Pain Therapeutics,...
Continue Reading
|
|
|
Paliperidone Prolonged Release Tablets is Janssen-Cilag International NV’s investigational prolonged release, once daily, oral medication for the treatment of schizophrenia that uses OROS technology, which releases drug into the bloodstream steadily over a 24-hour period. "Enhancing patient care for people...
Continue Reading
|
|
|
Phase 3 clinical trial of FEBT or fentanyl effervescent buccal tablet in all measures of pain control assessed in a chronic cancer pain population showed positive results. The study data were presented by Cephalon, Inc. at the annual meeting of...
Continue Reading
|
|
May15
|
The New York Times recently reported that Doctors are objecting to drug data gathering, a compilation of data showing which physicians are prescribing what drugs. Considered as the most potent weapon in pharmaceutical sales, once drug sales representatives knew of...
Continue Reading
|
|
|
The anticancer drug Taxol (paclitaxel) is derived from the bark of the Pacific yew, one of the slowest growing trees in the world. Reliance to this tree alone can have supply problems with the production of Taxol. Michigan State University researchers...
Continue Reading
|
|
|
Hepsera is an antiviral that Hepatitis B patients are currently taking. Its “nucleotide analog”, an investigational drug called Tenofovir is the same as Hepsera in helping stop the Hepatitis B virus from propagating. Hepatitis B is a disease passed down...
Continue Reading
|
|
|
Europe's third-biggest drugmaker AstraZeneca is buying off its research and development partner, Cambridge Antibody Technology Group Plc, for $1.32 billion. Investors in the Cambridge, England-based company will get 1,320 pence for each of their shares, AstraZeneca said today. That's 67...
Continue Reading
|
|
|
Israel-based biopharmaceutical firm D-Pharm Ltd announced that the company raised $10 million in a private round of investing, led by Clal Biotechnology Industries, Israel Healthcare Ventures and Pitango Venture Capital. Dr. Hadar Ron, of Israel Healthcare Ventures, who will join...
Continue Reading
|
|
May14
|
Paris-based biopharmaceutical company Diatos SA acquired exclusive worldwide development and commercialization rights to Gilead Sciences, Inc's DaunoXome (daunorubicin), a chemotherapeutic agent approved for AIDS/HIV-related Kaposi's sarcoma. Under the terms of the agreement, Diatos was granted exclusive worldwide development and commercialization...
Continue Reading
|
|
May13
|
The US Food and Drug Administration has approved Pfizer's smoking cessation drug, Chantix™ (varenicline), following a priority review. Chantix is unique because it is specifically designed to partially activate the nicotinic receptor and reduce the severity of the smoker's craving...
Continue Reading
|
|
|
Following a $65 million financing in April, biopharmaceutical company NeoRx will be changing its name to Poniard Pharmaceuticals, effective June 16, 2006. The firm is also moving its headquarters from Seattle to San Francisco in July. In addition to the...
Continue Reading
|
|
|
Tamiflu® is Roche’s leading prescription antiviral medication for the prevention and treatment of the influenza virus. It is the only oral antiviral that has shown activity in vitro and in animal studies against the H5N1 strain of the avian flu...
Continue Reading
|
|
|
Lawmakers and senor advocacy groups have asked for extension of signing up for the new Medicare Drug Coverage Program. But US President Bush has rejected all pleas reiterating that deadlines are important and that people should understand that there's finality...
Continue Reading
|
|
|
Guideline, Inc., one of the nation's largest providers of custom business research and analysis found in a recent national study that consumers are looking for both prescription medications and innovative sleep aids for relief of their insomnia. On what new...
Continue Reading
|
|
May12
|
A group of chemical compounds called furanocoumarins (not the flavonoids) are the substances in grape fruit juice that cause potentially dangerous interactions with certain medications, including some drugs that control blood pressure or lower cholesterol. According to previous studies, grapefruit...
Continue Reading
|
|
|
An antidepressant drug may reduce the risk of recurrent depression and increase the length of time between depressive episodes in diabetic patients, according to a study conducted by a research team at Washington University School of Medicine in St. Louis....
Continue Reading
|
|
|
As opposed to a 28-day cyclic regimen, a non-cyclic oral contraceptive, [90 µg levonorgestrel/20 µg ethinyl estradiol tablets] has to be taken every day of the year without a placebo (or sugar pill) interval but would result in a temporary...
Continue Reading
|
|
|
It has been two years since a couple of FDA Advisory Committees and scientists agreed that Plan B emergency contraception is safe and effective for over the counter use, up to present, FDA officials haven’t acted on this matter yet....
Continue Reading
|
|
May11
|
Cytogen Corporation has been cleared by the USFDA for its IND (investigational new drug) application for CYT-500, the company’s lead therapeutic candidate targeting prostate-specific membrane antigen (PSMA). CYT-500 uses the same monoclonal antibody from Cytogen's PROSTASCINT® (capromab pendetide) molecular imaging...
Continue Reading
|
|
|
The same virus that causes chicken pox, varicella-zoster virus is the cause of shingles (herpes zoster). This virus remains dormant in the nervous system for decades after infection with chickenpox and when reactivated, causes a rash and nerve pain (postherpetic...
Continue Reading
|
|
|
AstraZeneca collaborated with Abraxis BioScience Inc. (ABBI) to promote ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in the United States while Abraxis Bioscience Inc. acquired its US anaesthetics and analgesic products. USFDA approved in January 2005,...
Continue Reading
|
|
|
Neurocrine Biosciences, Inc. announced couple of weeks ago the positive results of the Phase II Clinical Trial of its proprietary, orally-active small molecule Gonadotropin-Releasing Hormone (GnRH) receptor antagonist (NBI-56418). The main goal of the study was reduction in the Composite...
Continue Reading
|
|
|
The US Patent and Trademark Office (PTO) proposed in January to change the patent rules that would restrict the number of claims examined in a single application and limit inventors'rights to file continuation applications. This proposition was opposed by the...
Continue Reading
|
|
May10
|
Roche signed a multifaceted agreement with Borean Pharma A/S, the Danish biopharmaceutical and protein engineering company, to acquire Trimeric Apo A-1- Borean Pharma’s lead candidate for the treatment of atherosclerosis, a form of heart disease. This acquisition forms a strategic...
Continue Reading
|
|
|
Details of a new German research showing that a drug called valproate (already used to treat epilepsy) could influence the behavior of a gene in patients with debilitating genetic condition have been presented at the European Society of Human Genetics...
Continue Reading
|
|
|
Privately-held biopharmaceutical industry Avidia announced that it has raised $43.8 million in a Series C financing round. Avidia plans to use the funds to further develop its pipeline, including an inhibitor of interleukin 6 for the treatment of inflammation and...
Continue Reading
|
|
|
Pharmaceutical leader Merck announced the acquisition of two biotech companies: GlycoFi, Inc. and Abmaxis, Inc. GlycoFi, based in Lebanon, specializes in yeast glycoengineering to produce protein therapeutics, and optimizing biologic drug molecules. Under the terms of the merger agreement, Merck...
Continue Reading
|
|
|
Cytogen Corporation recently announced that it has entered into a royalty buyout agreement with Berlex, Inc. for QUADRAMET® (samarium Sm-153 lexidronam injection). Indicated for the relief of pain in patients with confirmed osteoblastic metastatic bone lesions that enhance on radionuclide...
Continue Reading
|
|
May 9
|
Kos Life Sciences, Inc. (a subsidiary of Kos Pharmaceuticals, Inc.) and Jagotec AG (a subsidiary of SkyePharma PLC) entered into an exclusive marketing and distribution agreement for SkyePharma's Flutiform, a bronchodilator indicated against asthma. Flutiform is a combination of formoterol...
Continue Reading
|
|
|
Bioniche Life Sciences Inc.’s Mycobacterial Cell Wall-DNA Complex (MCC- Uricidin™) has been granted Fast Track designation by the USFDA for the treatment of non-muscle invasive bladder cancer in patients who are unresponsive to Bacillus Calmette-Guerin (BCG), the current standard therapy....
Continue Reading
|
|
|
Barr Laboratories, Inc., a Barr Pharmaceuticals, Inc. subsidiary is challenging the patents on Aventis Pharmaceuticals, Inc.’s NASACORT® AQ (Triamcinolone Acetonide) Nasal Spray. NASACORT AQ (Triamcinolone Acetonide) Nasal Spray is indicated for the treatment of the nasal symptoms of seasonal and...
Continue Reading
|
|
|
Data from a physician- sponsored clinical trial designed to compare the efficacy of Xibrom™(bromfenac ophthalmic solution) 0.09% with two topical non-steroidal anti- inflammatory solutions (NSAIDs) that were given four times a day for the treatment of acute pseudophakic cystoid macular...
Continue Reading
|
|
|
Seven months ago my father died of myocardial infarction or simply known as heart attack. The attack, (his first major and last) came while he was at sea, chest-deep. Nobody was close enough to save and revive him. His body...
Continue Reading
|
|
May 8
|
Duramed Pharmaceuticals, Inc. announced that Enjuvia (TM), a hormone replacement therapy pill, is now availbale in pharmacies nationwide. "ENJUVIA is a new option for American women electing, in consultation with their physicians, to use prescription hormone therapy and provides them...
Continue Reading
|
|
|
In order to remain healthy, patients with severe chronic anemia need frequent blood transfusions, a procedure that can cause a potentially deadly iron buildup in the body, in turn leading to liver and heart failures. There is a traditional treatment...
Continue Reading
|
|
|
Letrozole is an easy to use inexpensive drug for the treatment of infertility. Concerns for the use of this drug seem to be unfounded according to a major study conducted by a research team from McGill University Health Centre (MUHC)....
Continue Reading
|
|
|
According to an article published in the April 21, 2006 edition of the journal Science, researchers believe to have found a way to alter the action of 60% of currently available medications, maybe even make them many times more effective....
Continue Reading
|
|
|
Locteron™ is a product that Biolex Therapeutics is co-developing with OctoPlus which combines BLX-883 (Biolex’s recombinant alfa interferon in its patented LEX System (SM)) with Octoplus’ Polyactive™, an advanced controlled- release drug delivery technology. The Phase 1 trial demonstrated the...
Continue Reading
|
|
May 7
|
According to the results of The COMBINE Study (Combining Medications and Behavioral Interventions for Alcoholism), Naltrexone medication is equally effective with 20 sessions of alcohol counseling (by a behavioral specialist) as treatments for alcohol dependence when delivered with structured medical...
Continue Reading
|
|
|
The US largest distributor of influenza vaccines and human plasma products: FF Enterprises Inc., recently launched MyFluVaccine, a one-of-a-kind new program that allows healthcare providers to order flu vaccine for delivery on their specified dates for the upcoming influenza season....
Continue Reading
|
|
|
MGI Pharma, Inc. (Nasdaq: MOGN) and SuperGen, Inc. (Nasdaq: SUPG) ’s Dacogen™ (decitabine) for Injection is indicated for the treatment of patients with myelodysplastic syndromes (MDS) and was just recently approved by the USFDA. "The FDA approval of Dacogen marks...
Continue Reading
|
|
|
Monkeys have completely been protected from anthrax when treated with a vaccine in combination with a short-course of antibiotics. This strategy offers a more realistic in protecting people against the deadly anthrax in cases of biological attack according to the...
Continue Reading
|
|
|
According to a rat study, a urine test could accurately predict how a person will react to medications. This is importantly useful instead of genetic screening which has been the major approach being used at present This new test relies...
Continue Reading
|
|
|
Corona, California-based Watson Pharma Inc. is a leading specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. In lieu of the company’s pending acquisition of Andrx, both Watson Pharmaceuticals, Inc. (NYSE: WPI) and Andrx Corporation...
Continue Reading
|
|
May 6
|
Researchers at the University of Georgia have developed an anti-microbial treatment that adheres to the skin but without being toxic. The compound, known as Tricide, was initially developed by now retired UGA professor Dr. Richard Wooley to treat burns. Later...
Continue Reading
|
|
|
As presented recently at the annual meeting of the Pediatric Academic Societies in San Francisco, an intranasal influenza vaccine proved to be more effective that the injectable forms in children older than 6 moths and younger than 5 years of...
Continue Reading
|
|
May 5
|
As part of the US Department of Health and Human Services' Pandemic Influenza Plan, the government awarded a total of $1 billion in contracts to the following pharmaceutical companies to develop and manufacture influenza vaccines (click links to see individual...
Continue Reading
|
|
|
Using nicotine patches or Zyban will double the chances to quit smoking than those who do not use medication at all. However, despite the relative effactiveness of anti-smoking medications available in the market, 80% of recent quitters are most likely...
Continue Reading
|
|
|
Findings appearing in the May 3 issue of the European Journal of Cancer states that a molecule that interferes with the internal scaffolding that shapes the cell may kill cancer cells, retard the growth of tumors and give a...
Continue Reading
|
|
May 4
|
In lieu of the new study results stating that even the short-term use of the painkiller Vioxx® increases the risks of heart attack in older people; Merck & Co., the maker of Vioxx® may be facing new Vioxx lawsuits as...
Continue Reading
|
|
|
Ester-C is Zila Nutraceuticals’ newly developed and patented form of Vitamin C that is said to offer improved antioxidant and anti-carcinogenic powers which would allow it to be on top of the Vitamin C market. Zila Nutraceuticals is a company...
Continue Reading
|
|
|
By acquiring Conforma Therapeutics Corporation, Biogen Idec expands its oncology pipeline, adding two compounds underr Phase 1 clinical trials: CNF1010, a proprietary form of the geldanamycin derivative 17-AAG CNF2024, a totally synthetic, orally bioavailable HSP90 inhibitor The transaction is expected...
Continue Reading
|
|
|
Japan-based Astellas Pharma Inc. acquired exclusive marketing rights to Fibrogen's two investigational oral therapies for anemia, designated as FG-2216 and FG-4592. Under the agreement, Astellas will pay a upfront fees of US$ 300 million to FibroGen upon signing of the...
Continue Reading
|
|
|
The "Big Pharma" industry (those with annual revenues >$10bn) has had a negative outlook the past few years due to a number of factors such as generic competition, lean product pipelines, and the uncertainty of the Medicare drug benefits. According...
Continue Reading
|
|
May 3
|
Insmed Inc. recently announced the results of the clinical trial of rhIGF-I/rhIGFBP-3, or IPLEX™ (mecasermin rinfabate [rDNA origin] injection) administered once daily to children with severe primary insulin-like growth factor-I (IGF-I) deficiency. The data from the study as presented at...
Continue Reading
|
|
|
Cephalon Inc.’s NUVIGIL™ (armodafinil) received an approvable letter for the company’s USFDA NDA (new drug application) to market the drug for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSA/HS) and shift work sleep disorder (SWSD)....
Continue Reading
|
|
May 2
|
Basilea Pharmaceutical's novel broad-spectrum water soluble antifungal, BAL8557, has been granted a fast track designation by the US FDA. BAL8557 has been shown in clinical trials to be effective against most yeasts and molds, including fluconazole resistant candida strains, aspergillus...
Continue Reading
|
|
|
PainCeptor Pharma Corp. has entered into a development collaboration with Argenta Discovery Ltd.. Under the terms of the agreement, scientists from the two companies will exploit Argenta's expertise in computer-aided drug design (CADD) and medicinal chemistry to accelerate PainCeptor's ASIC...
Continue Reading
|
|
|
Bristol-Myers Squibb has confirmed that it plans to halt the production and marketing of Tequin, a antibiotic prescribed for chronic bronchitis, sinusitis, pneumonia, urinary tract and other infections. The antibiotic has been reported to have serious side effects on blood...
Continue Reading
|
|
May 1
|
What: Specialty Pharmaceuticals Summit When: June 6-8, 2006 Where: Park Hyatt Hotel at the Bellevue, Philadelphia, PA, Executives from specialty pharma, large pharma and other vested parties are coming together to share perspectives and experiences on crucial issues. With...
Continue Reading
|
|
|
Isis Pharmaceuticals, Inc.’s (Nasdaq: ISIS) ISIS 301012’s Phase 2 clinical trial as a single-agent in patients with high cholesterol resulted to the following: at a dose of 200 mg/wk for three months, ISIS 301012 achieved a median percent reduction...
Continue Reading
|
|
|
Canada’s The Calgary Sun reported that Health Canada has warned the public on tablets in the market that maybe contaminated with E.Coli. These two products are LifeTime Complexed Potassium 99 mg tablets and Miracle Bion. Read Health Canada's advisories...
Continue Reading
|
|
|
A new technology will enable pharmaceutical companies to determine more effectively and earlier on the onset of clinical trials if an experimental drug is toxic to the heart. Such a technology is now gearing towards the market with...
Continue Reading
|
